Processa (PCSA) news
Recent news
ImportantProcessa Pharmaceuticals announces closing of $5 million public offering priced at-the-market under Nasdaq rules
Processa Pharmaceuticals announces closing of $5 million public offering priced at-the-market under Nasdaq rules Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company specializing in the development of next-generation chemotherapeutic drugs, announced the successful…
AInvest Wire · Jan 30, 2025ImportantProcessa stock rallies 35% post-market on Phase 2 study update
Processa stock rallies 35% post-market on Phase 2 study update Processa Pharmaceuticals, a clinical-stage pharmaceutical company focused on improving cancer treatment outcomes, recently announced successful outcomes from a meeting with the U.S. Food and Drug Administration (FDA) regarding the…
AInvest Wire · Oct 2, 2024ImportantProcessa Pharmaceuticals Shares Drop 20% After Pricing Offering
Processa Pharmaceuticals Shares Drop 20% After Pricing Offering Processa Pharmaceuticals, a clinical-stage pharmaceutical company, recently announced that it will effect a 1-for-20 reverse stock split [1]. The company's Board of Directors determined the split ratio on January 8, 2024, and the…
AInvest Wire · Jan 26, 2024ImportantProcessa Pharmaceuticals jumps 24% premarket afer completing Phase 1b Safety Evaluation
AInvest Wire · Jan 26, 2024ImportantProcessa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatment
Processa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatment Processa Pharmaceuticals, a clinical-stage biopharmaceutical company, recently announced the successful completion of a Phase 1b safety evaluation of NGC-Cap, a next-generation capecitabine, in…
AInvest Wire · Jan 25, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.